Descripción del producto

~Diatrizoate Meglumine and Diatrizoate Sodium Injection is a radiopaque contrast agent supplied as a sterile, aqueous solution, intended for intravascular administration, it contains the meglumine salt and the sodium slat of diatrizoic acid (3,5 - diacetamido - 2,4,*-triiodobenzoic acid). Dibasic Sodium Phosphate has been added as a buffer, and Edetate Calcium Disodium as a stabilizing agent. The solution is clear, colorless to pale yellow.
Diatrizoate Meglumine and Diatrizoate Sodium Injection *0% contains 0.*4g Diatrizoate Sodium and 0.*6g Diatrizoate Meglumine per mL in aqueous solution.
Diatrizoate Meglumine and Diatrizoate Sodium Injection *0% contains 0.*8g Diatrizoate Sodium and 0.*2g Diatrizoate Meglumine per mL in aqueous solution.
Diatrizoate Meglumine and Diatrizoate Sodium Injection *0% contains 0.1g Diatrizoate Sodium and 0.*6g Diatrizoate Meglumine per mL in aqueous solution